Ownership history in BB BIOTECH AG · 15 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Esperion Therapeutics (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | ADDED | 3,522,964 | +130,000 | +3.8% | 3.56% | $141.4M | $40.15 |
| 2018 Q4 | ADDED | 3,392,964 | +110,000 | +3.4% | 5.00% | $156.1M | $46.00 |
| 2018 Q3 | ADDED | 3,282,964 | +100,000 | +3.1% | 3.85% | $145.7M | $44.37 |
| 2018 Q2 | ADDED | 3,182,964 | +770,000 | +31.9% | 3.60% | $124.7M | $39.19 |
| 2018 Q1 | ADDED | 2,412,964 | +50,000 | +2.1% | 4.82% | $174.5M | $72.33 |
| 2017 Q4 | ADDED | 2,362,964 | +265,000 | +12.6% | 4.38% | $155.6M | $65.84 |
| 2017 Q3 | ADDED | 2,097,964 | +584,422 | +38.6% | 2.91% | $105.2M | $50.12 |
| 2017 Q2 | ADDED | 1,513,542 | +105,000 | +7.5% | 2.14% | $70.0M | $46.28 |
| 2017 Q1 | ADDED | 1,408,542 | +100,000 | +7.6% | 1.63% | $49.7M | $35.31 |
| 2016 Q4 | UNCHANGED | 1,308,542 | — | 0% | 0.61% | $16.4M | $12.52 |
As of 2025 Q4 — sorted by position size